Limitations with aprotinin in thoracic aortic surgery: understanding the clinical outcome beyond bleeding.
作者信息
Augoustides John G T
出版信息
J Thorac Cardiovasc Surg. 2007 Jul;134(1):269; author reply 269. doi: 10.1016/j.jtcvs.2006.11.071.
PMID:17599543
Abstract
摘要
相似文献
1
Limitations with aprotinin in thoracic aortic surgery: understanding the clinical outcome beyond bleeding.胸主动脉手术中抑肽酶的局限性：了解出血以外的临床结局
J Thorac Cardiovasc Surg. 2007 Jul;134(1):269; author reply 269. doi: 10.1016/j.jtcvs.2006.11.071.
2
Aprotinin use in thoracic aortic surgery: safety and outcomes.
J Thorac Cardiovasc Surg. 2006 Oct;132(4):909-17. doi: 10.1016/j.jtcvs.2006.06.021.
3
Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction.抑肽酶用于择期主动脉重建的前瞻性随机安慰剂对照试验。
Br J Surg. 1997 Aug;84(8):1110-3.
4
A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.中国某单一心脏中心心脏手术中抑肽酶停用前后的比较：现实世界中的不同结果
J Thorac Cardiovasc Surg. 2009 Oct;138(4):897-903. doi: 10.1016/j.jtcvs.2009.03.021. Epub 2009 May 21.
5
Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
J Cardiothorac Vasc Anesth. 2007 Apr;21(2):302-4. doi: 10.1053/j.jvca.2007.01.002.
6
Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
J Cardiothorac Vasc Anesth. 2007 Apr;21(2):298-301. doi: 10.1053/j.jvca.2006.11.009. Epub 2007 Feb 7.
7
Aprotinin in cardiac surgery.心脏手术中的抑肽酶
N Engl J Med. 2006 May 4;354(18):1953-7; author reply 1953-7.
8
Coagulation in cardiac surgery.心脏手术中的凝血
Adv Card Surg. 1996;8:19-45.
9
Aprotinin in cardiac surgery.心脏手术中的抑肽酶
N Engl J Med. 2006 May 4;354(18):1953-7; author reply 1953-7. doi: 10.1056/NEJMc066081.
10
Aprotinin in cardiac surgery.抑肽酶在心脏手术中的应用
N Engl J Med. 2006 May 4;354(18):1953-7; author reply 1953-7.
Zotero 插件